ANI Pharmaceuticals Inc (ANIP) insider trading
Every open-market stock purchase and sale by ANI Pharmaceuticals Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Stephen P. Carey (CFO) and 4 others sold $2.1M in the last 90 days.
- Last insider buy: Nikhil Lalwani (CEO), $200K, 4 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $15.1M (42 sales). Last close $76.14 on Sep 18, 2026.
Recent ANIP insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 29, 2026 | Stephen P. Carey (CFO) | Sold | $208K |
| Sep 15, 2026 | Nikhil Lalwani (CEO) | Sold | $383K |
| Sep 14, 2026 | Meredith Cook (VP) | Sold | $35.4K |
| Sep 11, 2026 | Jeanne Thoma (Director) | Sold | $71.5K |
| Aug 31, 2026 | Stephen P. Carey (CFO) | Sold | $207K |
| Aug 25, 2026 | Nikhil Lalwani (CEO) | Sold | $401K |
| Aug 19, 2026 | Henry O Gosebruch (Director) | Bought (not open market) | — |
| Aug 13, 2026 | Meredith Cook (VP) | Sold | $37.7K |
| Aug 10, 2026 | Ori Gutwerg (VP) | Sold | $243K |
| Jul 29, 2026 | Stephen P. Carey (CFO) | Sold | $232K |
| Jul 18, 2026 | Meredith Cook (VP) | Sold (not open market) | $195K |
| Jul 13, 2026 | Meredith Cook (VP) | Sold | $40.9K |
| Jul 2, 2026 | Stephen P. Carey (CFO) | Sold | $285K |
| Jul 2, 2026 | Stephen P. Carey (CFO) | Bought (not open market) | $164K |
| Jun 29, 2026 | Stephen P. Carey (CFO) | Sold | $240K |
| Jun 12, 2026 | Meredith Cook (VP) | Sold | $41K |
| Jun 8, 2026 | Thomas Haughey (Director) | Sold | $162K |
| Jun 5, 2026 | Stephen P. Carey (CFO) | Sold | $265K |
| Jun 5, 2026 | Stephen P. Carey (CFO) | Bought (not open market) | $164K |
| May 21, 2026 | Matthew J Leonard (Director) | Bought (not open market) | — |
| May 21, 2026 | Antonio R Pera (Director) | Bought (not open market) | — |
| May 21, 2026 | Jeanne Thoma (Director) | Bought (not open market) | — |
| May 21, 2026 | Thomas Haughey (Director) | Bought (not open market) | — |
| May 21, 2026 | Renee P Tannenbaum (Director) | Bought (not open market) | — |
| May 13, 2026 | Patrick D Walsh (Director) | Sold | $806K |
Who's trading ANIP
- Stephen P. Carey, CFO: sold $2M (8 sales), last Sep 29, 2026
- Nikhil Lalwani, CEO: sold $5.1M (3 sales), last Sep 15, 2026
- Meredith Cook, VP: sold $454K (12 sales), last Sep 14, 2026
- Jeanne Thoma, Director: sold $71.5K (1 sale), last Sep 11, 2026
- Henry O Gosebruch, Director: other filings, last Aug 19, 2026
- Ori Gutwerg, VP: sold $621K (3 sales), last Aug 10, 2026
- Thomas Haughey, Director: sold $162K (1 sale), last Jun 8, 2026
- Matthew J Leonard, Director: other filings, last May 21, 2026
- Antonio R Pera, Director: other filings, last May 21, 2026
- Renee P Tannenbaum, Director: sold $146K (1 sale), last May 21, 2026
- Patrick D Walsh, Director: sold $2.3M (4 sales), last May 13, 2026
- Thomas Andrew Rowland, VP: sold $394K (2 sales), last May 12, 2026
- Christopher Mutz, Officer: sold $1.6M (6 sales), last Mar 13, 2026
- Krista Davis, C-suite exec: sold $919K (5 sales), last Mar 9, 2026
- Chad Gassert, VP: sold $1.3M (2 sales), last Feb 28, 2026
Get free alerts when an insider at ANI Pharmaceuticals Inc files a new trade →